Jefferies analyst Eun Yang initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy rating and announces Price Target of $35.
When Could SpaceX Hit 69 Launches A Year? Here’s What Elon Musk Said
Space company SpaceX has been at the forefront of rocket launches over the past several years, vaulting the company and the space industry to new heights.
Earlier this year, NASA highlighted an ambitious launch schedule from SpaceX. The guidance may have been conservative.
